DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Pneumonia in patients who require prolonged mechanical ventilation.

Author(s): Rumbak MJ

Affiliation(s): Department of Internal Medicine, University of South Florida College of Medicine, University of South Florida, 12901 Bruce B. Downs Blvd., MDC 19, Tampa, FL 33612-4799, USA. dmrumcake@aol.com

Publication date & source: 2005-02, Microbes Infect., 7(2):275-8. Epub 2005 Jan 8.

Nosocomial pneumonia is the most important infectious disease in patients who require prolonged mechanical ventilation. Understanding of the etiology helps to prevent ventilator-associated pneumonia (VAP). VAP can develop in four ways: by aspiration, inhalation, hematogenous spread and by contiguous spread. The two most common are aspiration from the oropharyngeal region and inhalation, usually from manipulation of tubing or infected equipment. VAP is prevented by hand-washing, keeping the head of the bed at 45 and, in some cases, by treating the surface bacteria which usually cause VAP. Sputum can be used for the diagnosis of VAP in most of these patients instead of invasive bronchoscopy. However, if the patients are critically ill, then bronchoscopy is used. Treatment in these patients depends on the bacteria. Pseudomonas is treated by two drugs (beta-lactam plus a quinolone or aminoglycoside), Acinetobacteria by ampicillin/sulbactam or carbapenam, extended-spectrum beta-lactam-producing bacteria by carbapenums, and Staphylococcus by vancomycin or linezolid.

Page last updated: 2007-02-13

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017